TLR3 and cancer: Indeed, anthracyclines, such as viruses, lead to cancer cell-autonomous, TLR3-mediated, Type I IFN production, that triggers autocrine and paracrine IFNAR-dependent circuits, finally resulting in the expression of various ISGs, including CXCL10 (known to recruit innate immune cells).